Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Ren Nutr ; 23(1): 45-56, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22406123

RESUMO

OBJECTIVES: We sought to investigate the interaction of adiponectin levels and body mass index (BMI) for predicting all-cause mortality in a cohort of hemodialysis (HD) patients. DESIGN: Longitudinal, observational cohort study. SETTING: HD unit. SUBJECTS: Sixty patients (mean age: 64 ± 13 years, 39 men) with end-stage renal disease on maintenance HD followed up for 4.5 years represented the prospective study cohort. INTERVENTION: Associations between baseline plasma adiponectin levels and initial BMI with all-cause mortality were assessed taking into account the assumption of nonlinear correlations. The association between adiponectin, BMI, and serum levels of interleukin-10 (IL-10) and interleukin-6 (IL-6) with survival was determined cross-sectionally. MAIN OUTCOME MEASURE: All-cause mortality. RESULTS: Nonlinear survival modeling showed that there was a U-shaped association of BMI with all-cause mortality, whereas there was an inverse U-shaped association for plasma adiponectin levels. Using a BMI of 24 kg/m(2) as a cutoff, an interaction effect of BMI on the association between adiponectin and mortality was observed (P = .045). In participants with BMI ≥ 24 kg/m(2), each 15 µg/mL increase in plasma adiponectin levels was associated with a decreased hazard of death (hazard ratio: 0.57, 95% CI: 0.32 to 0.99) in unadjusted analysis. In HD patients with BMI < 24 kg/m(2), no significant association was observed between adiponectin and mortality (P = .989). Cross-sectional analysis showed that in the subgroup of patients in whom the protective effect of adiponectin was observed (BMI ≥ 24 kg/m(2)), a positive linear association existed between adiponectin and IL-10 levels (r = 0.345, P = .027) as well as a negative association with IL-6 levels (r = -0.322, P = .040). No association was observed in patients with BMI < 24 kg/m(2), neither with IL-10 nor with IL-6. CONCLUSIONS: Obesity possibly modifies the effect of adiponectin on all-cause mortality in HD patients, thus explaining the published conflicting results in recent literature regarding the association of plasma adiponectin levels and mortality in chronic kidney disease patients.


Assuntos
Adiponectina/sangue , Índice de Massa Corporal , Diálise Renal/mortalidade , Idoso , Feminino , Seguimentos , Humanos , Interleucina-10/sangue , Interleucina-6/sangue , Falência Renal Crônica/sangue , Falência Renal Crônica/mortalidade , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Modelos de Riscos Proporcionais
2.
Eur J Pediatr ; 168(3): 343-6, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18463893

RESUMO

We report a very unusual case of meningoencephalitis due to Listeria monocytogenes in a 7-month-old immunocompetent boy. Cerebrospinal fluid (CSF) culture was initially negative, but was positive on the seventh day. The disease was complicated by seizures and hydrocephalus managed with temporary ventriculostomy. The infant was discharged without obvious neurological sequelae after 30 days and developed without neurological or developmental sequelae at two years of age. Listeria is difficult to isolate and is not susceptible to third-generation cephalosporins commonly used for the empirical treatment of bacterial meningitis.


Assuntos
Hidrocefalia/complicações , Hidrocefalia/diagnóstico , Meningite por Listeria/complicações , Meningite por Listeria/diagnóstico , Ampicilina/uso terapêutico , Antibacterianos/uso terapêutico , Anticonvulsivantes/uso terapêutico , Ceftriaxona/uso terapêutico , Quimioterapia Combinada , Gentamicinas/uso terapêutico , Humanos , Hidrocefalia/tratamento farmacológico , Imunocompetência , Lactente , Masculino , Meningite por Listeria/tratamento farmacológico , Fenitoína/uso terapêutico , Convulsões/tratamento farmacológico , Convulsões/etiologia , Tomografia Computadorizada por Raios X , Vancomicina/uso terapêutico
3.
Eur J Dermatol ; 17(5): 443-5, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17673392

RESUMO

Bacillus anthracis disease constitutes an extremely important worldwide epidemiological problem. Interest in cutaneous anthrax resides in its skin manifestations, course, diagnostic methods and management. An extensive cutaneous anthrax of the whole left upper arm, accompanied by lymphadenopathy and high fever, in a 60 year-old male patient, a shepherd by profession, is reported. He was treated effectively by intravenously administered ciprofloxacin and clindamycin. In the event of clinical suspicion of cutaneous anthrax, the patient has to be treated by the recommended regimen of antibiotics because of the possibility of evolvution to an extensive or severe systemic disease, even in the absence of immuno-depressant factors.


Assuntos
Antraz/patologia , Bacillus anthracis/isolamento & purificação , Dermatopatias Bacterianas/patologia , Antraz/tratamento farmacológico , Antibacterianos/administração & dosagem , Ciprofloxacina/administração & dosagem , Clindamicina/administração & dosagem , Quimioterapia Combinada , Humanos , Imunocompetência , Infusões Intravenosas , Masculino , Pessoa de Meia-Idade , Dermatopatias Bacterianas/tratamento farmacológico
4.
Pediatr Int ; 50(1): 51-6, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18279205

RESUMO

BACKGROUND: The purpose of the present retrospective study was to investigate the association of school-age asthma with acute-bronchiolitis and examine the influence of potential risk factors. METHODS: One hundred and eighty-nine children aged 7.5 +/- 2.2 years consecutively hospitalized for respiratory syncytial virus (RSV)-positive acute bronchiolitis during infancy were evaluated by clinical examination and measurement of peak expiratory flow (PEFR), spirometry, IgE and skin-prick testing. Their pulmonary function was compared with that of 60 non-asthmatic matched controls. RESULTS: Of the entire cohort 57.1% were diagnosed as asthmatic. PEFR, the 1-second forced expiratory volume and forced expiratory flow of 50% vital capacity of children with a history of acute bronchiolitis were statistically significantly lower than in the control group (all P < 0.001). All the aforementioned measurements of children with/without asthma were also significantly lower than controls, while values of asthmatics were significantly lower than those of non-asthmatics. The incidence of asthma in childhood was independently associated with breast-feeding <3 months (adjusted odds ratio [aOR], 8.4; 95% confidence interval [CI]: 3.1-22.4), at least one positive skin prick test (aOR, 7.1; 95%CI: 2.8-18.1), male gender (aOR, 5.0; 95%CI: 2.2-11.5), evidence of moisture in the home environment (aOR, 2.9; 95%CI: 1.3-6.3) and presence of more than one house-resident smoking indoors (aOR, 4.9; 95%CI: 1.8-9.2). CONCLUSION: Children with a history of RSV-bronchiolitis during infancy have an increased risk for developing asthma in childhood, which was independently associated with male gender, breast-feeding <3 months, living in a home environment with moisture damage and/or tobacco smoke by two or more residents and sensitization to at least one aeroallergen. Children with a history of RSV bronchiolitis in infancy had lower spirometry in comparison to matched control group. The difference was more marked for asthmatic ones but remained significant even for non-asthmatic children.


Assuntos
Asma/etiologia , Asma/fisiopatologia , Bronquite/complicações , Pulmão/fisiopatologia , Hipersensibilidade Respiratória/complicações , Infecções por Vírus Respiratório Sincicial/complicações , Adolescente , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Testes de Função Respiratória , Estudos Retrospectivos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa